Currency
GBP; prices are not US dollars
Standard kit
£350 one-time
Pen and full kit
£375 one-time
Capsules
£75 / 30-capsule jar
Market
UK-focused; US availability not established

A different market and purchasing model

NAD+ AT HOME publishes a UK-focused storefront with injectable vial kits, injection pens and liposomal NAD+ capsules. Its standard prices are expressed in pounds, unlike the US dollar offers that make up most of this register. We retain GBP labels throughout the reviews and do not treat the numbers as equivalent dollar amounts.

The delivery policy principally describes England, Scotland, Wales and Northern Ireland, with occasional deliveries elsewhere. That wording does not establish routine US availability or the conditions under which an injectable product could be supplied to a particular reader. Confirm location, clinical requirements and the complete delivery arrangement directly before interpreting a .com address as a worldwide service promise.

Three separately documented products

The rendered storefront showed a £350 injection vial kit, a £375 pen and full kit, and a £75 jar of thirty liposomal capsules. Each has its own review because the purchase contents and route differ. The pen's initial hardware is relevant to its price, while an oral supplement is not a substitute specification for an injectable preparation.

The kit and pen pages list total NAD+ quantities, but those figures should not be converted into a treatment schedule by a price guide. Package labels, storage conditions and instructions need to be confirmed for the actual product supplied. A comparison based only on the total amount would overlook the different formulations and routes.

Subscription selectors change both price and timing

The checked vial selector displayed £280 for a four-week subscription option, compared with £350 for a single purchase. The pen selector showed £300 for a monthly option against £375 one-time, and the capsule selector showed £60 monthly against £75 one-time. These are selected offers, not a promise that every delivery frequency receives the same reduction.

The general billing policy describes additional frequencies and discounts, so the checkout selection deserves a careful reading. Record the exact product, first charge, refill contents and renewal date. In particular, establish whether a subsequent pen order contains another device or only compatible refills, rather than assuming every shipment duplicates the initial kit.

Evidence and product oversight still need examination

The seller makes strong claims about absorption and healthy-aging benefits. We have not verified comparative clinical outcomes for these finished products, and a delivery mechanism or certificate-of-analysis claim cannot establish those outcomes on its own. Request the relevant documents and ask what testing covers the preparation being considered.

The site's UK commercial presentation should also remain separate from US prescription and regulatory assumptions. We did not establish a US prescribing pathway or approval status for these particular offers. This profile adds a transparent international comparison with known currency and package choices, while keeping clinical suitability, cross-border access and the evidence behind the marketing as questions requiring specific answers.

Useful distinctions

  • Three formats documented individually
  • One-time and subscription selectors visible
  • Delivery policy defines its main market

Limitations to weigh

  • Cross-border eligibility and supply not established
  • Different delivery frequencies change the offer
  • Absorption and outcome claims not independently verified

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. NAD+ AT HOME: injection kit Provider
  2. NAD+ AT HOME: injection pen and full kit Provider
  3. NAD+ AT HOME: liposomal capsules Provider
  4. NAD+ AT HOME: delivery policy Provider
  5. NAD+ AT HOME: pricing and billing policy Provider